News ArticleSai Parenterals Fully Acquires SP Analytics and Completes 60% Stake Purchase in Saicriti Pharma
Board approves acquisition to make SP Analytics a wholly owned subsidiary and confirms Saicriti Pharma's subsidiary status as of November 2026
Sai Parenterals Limited has acquired the remaining 25% equity stake in SP Analytics Private Limited, making it a wholly owned subsidiary. Additionally, Sai Parenterals completed the acquisition of a 60% stake in Saicriti Pharma Private Limited, establishing it as a subsidiary. The transactions reflect integral expansion moves within the pharma sector by the company as reported for the half year ended September 30, 2026.
Sai Parenterals Limited
Financial Results
Sai Parenterals Limited has acquired the remaining 25% shareholding in SP Analytics Private Limited, making it a wholly owned subsidiary, and has completed acquisition of a 60% stake in Saicriti Pharma Private Limited, effectively making it a subsidiary from the acquisition date.
The acquisitions were approved in the Board meeting held on November 1, 2026, at the company's registered office.
SP Analytics Private Limited, incorporated on November 16, 2023, operates in the pharmaceutical testing and analysis sector and had a nil turnover in the last three financial years.
The purchase of the remaining 2,500 equity shares of SP Analytics was for a total consideration of Rs. 25,000 in cash, making Sai Parenterals the sole owner of the entity.
The acquisition transaction was a related party transaction and conducted at arm's length terms, with no governmental approvals required and was expected to complete by December 31, 2026.
Separately, Sai Parenterals completed the previously approved acquisition of 60% equity share capital of Saicriti Pharma Private Limited, establishing it as a subsidiary company effective from the acquisition completion date.
Highlights
- Acquisition of remaining 25% equity stake in SP Analytics Private Limited for Rs. 25,000 completed.
- SP Analytics becomes wholly owned subsidiary of Sai Parenterals.
- Acquisition of 60% stake in Saicriti Pharma Private Limited completed, making it a subsidiary.
- Both acquisitions mark strategic expansions within the pharma sector.
- Board meeting held on November 1, 2026, approved the acquisitions and new management committee constitution.
Key Data Snapshot
What happened
- Sai Parenterals completed acquisition of remaining 25% equity in SP Analytics Private Limited, gaining full ownership.
- The company finalized the acquisition of 60% equity in Saicriti Pharma Private Limited, making it a subsidiary.
Key details
- The SP Analytics acquisition was a related party transaction conducted at arm’s length.
- No government or regulatory approvals were needed for the SP Analytics acquisition.
- Acquisition cost for SP Analytics shares was Rs. 25,000 paid in cash.
- SP Analytics was incorporated on November 16, 2023, with nil turnover in the last three years.
- Saicriti Pharma became a subsidiary effective upon completion of acquisition, as pre-approved on August 11, 2026.
Regulatory and governance context
- The Board meeting convened on November 1, 2026, also constituted a Management Committee to oversee company administration.
- The acquisition of SP Analytics falls under related party transaction regulations as per SEBI Listing Obligations and Disclosure Requirements.
- Sai Parenterals’ financial results for the quarter and half year ended September 30, 2026 were approved during the same meeting.
- Limited Review reports for the same period were received with no qualifications.
Highlights
- Acquisition of remaining 25% equity stake in SP Analytics Private Limited for Rs. 25,000 completed.
- SP Analytics becomes wholly owned subsidiary of Sai Parenterals.
- Acquisition of 60% stake in Saicriti Pharma Private Limited completed, making it a subsidiary.
- Both acquisitions mark strategic expansions within the pharma sector.
- Board meeting held on November 1, 2026, approved the acquisitions and new management committee constitution.
Disclosures
- SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
- Companies Act, 2013
Acquisition of SP Analytics Private Limited is a related party transaction with promoter interest, conducted at arm's length.
Promoter/Promoter Group has interest in SP Analytics by virtue of relationships with the entity.
More News on Financial Results
View allLatest corporate announcements and market updates in Financial Results.
Muthoot Finance Posts Unaudited Standalone and Consolidated Financial Results for Q2 and H1 Ending September 30, 2026
Muthoot Finance Limited announced its unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, showcasing key financial metrics under Indian Accounting Standard 34 and RBI prudential norms.
Read Full Story
Aditya Vision Limited Revises Q2 and H1 FY27 Earnings Per Share in Unaudited Financial Results
Aditya Vision Limited has filed a corrigendum to its unaudited financial results for the quarter and half-year ended September 30, 2026, correcting the earnings per share due to an inadvertent rounding error. The rest of the financial figures remain the same as previously reported.
Read Full Story
Power Grid Corporation Reports Rs. 11,900 Crore Income for Q2 FY2026-27 and Announces Rs. 3.00 Interim Dividend
Power Grid Corporation of India Limited released its unaudited standalone and consolidated financial results for the quarter and half year ended 30th September 2026, with a total income of Rs. 11,899.96 crore for the quarter. The company also declared a first interim dividend of Rs. 3.00 per equity share for the financial year 2026-27, payable to shareholders on 30th November 2026.
Read Full Story
